
SLN Valuation
Silence Therapeutics PLC
- Overview
- Forecast
- Valuation
- Earnings
SLN Relative Valuation
SLN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SLN is overvalued; if below, it's undervalued.
Historical Valuation
Silence Therapeutics PLC (SLN) is now in the Fair zone, suggesting that its current forward PS ratio of 14.84 is considered Fairly compared with the five-year average of -14.80. The fair price of Silence Therapeutics PLC (SLN) is between 1.28 to 19.62 according to relative valuation methord.
Relative Value
Fair Zone
1.28-19.62
Current Price:6.15
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.62
P/B
Median3y
7.52
Median5y
17.77
-24.37
FCF Yield
Median3y
-15.53
Median5y
-10.80
Competitors Valuation Multiple
The average P/S ratio for SLN's competitors is 12.18, providing a benchmark for relative valuation. Silence Therapeutics PLC Corp (SLN) exhibits a P/S ratio of 14.84, which is 21.79% above the industry average. Given its robust revenue growth of -99.10%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

ANIK
Anika Therapeutics Inc
11.500
USD
+4.55%

CDTX
Cidara Therapeutics Inc
64.850
USD
+5.40%

PKBK
Parke Bancorp Inc
22.190
USD
+1.00%

FET
Forum Energy Technologies Inc
19.800
USD
+3.39%

FF
FutureFuel Corp
4.220
USD
+2.18%

CLBR
Colombier Acquisition Corp II
0
USD
+1.62%

VSTM
Verastem Inc
5.350
USD
+1.52%

AOMR
Angel Oak Mortgage REIT Inc
9.640
USD
+0.52%

BWFG
Bankwell Financial Group Inc
37.600
USD
-1.08%

NWFL
Norwood Financial Corp
24.860
USD
+1.22%
FAQ

Is Silence Therapeutics PLC (SLN) currently overvalued or undervalued?
Silence Therapeutics PLC (SLN) is now in the Fair zone, suggesting that its current forward PS ratio of 14.84 is considered Fairly compared with the five-year average of -14.80. The fair price of Silence Therapeutics PLC (SLN) is between 1.28 to 19.62 according to relative valuation methord.

What is Silence Therapeutics PLC (SLN) fair value?

How does SLN's valuation metrics compare to the industry average?

What is the current P/B ratio for Silence Therapeutics PLC (SLN) as of Jul 24 2025?

What is the current FCF Yield for Silence Therapeutics PLC (SLN) as of Jul 24 2025?

What is the current Forward P/E ratio for Silence Therapeutics PLC (SLN) as of Jul 24 2025?
